Epidermal growth factor receptor (EGFR) inhibitor induced purpuric drug eruption: Three case reports

INTRODUCTION: Purpuric drug eruption (PDE) is an uncommon, clinically distinct side effect of epidermal growth factor receptor (EGFR) inhibitors. PATIENT CONCERNS: Unlike acneiform eruption, which arises from hair follicles mainly in the head and neck area, PDE starts from xerosis cutis, primarily i...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Szu-Yun, Wu, Chieh-Shan, Liu, Yi-Shan, Wei, Kai-Che
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882566/
https://www.ncbi.nlm.nih.gov/pubmed/31764850
http://dx.doi.org/10.1097/MD.0000000000018112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882566/
https://www.ncbi.nlm.nih.gov/pubmed/31764850
http://dx.doi.org/10.1097/MD.0000000000018112

Ejemplares similares